Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hofmann

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Nature|August 14, 2012
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signallingMarcus Dühren-von Minden, Rudolf Übelhart, Dunja Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology AssessmentOleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
Plos Pathogens|November 8, 2019
Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteinsJose A Quiroz, Ryan J Malonis, Larissa B Thackray, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Nature|August 14, 2012
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signallingMarcus Dühren-von Minden, Rudolf Übelhart, Dunja Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology AssessmentOleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
Plos Pathogens|November 8, 2019
Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteinsJose A Quiroz, Ryan J Malonis, Larissa B Thackray, et al.
Pageof 4